Google Doubles Down on Spending as AI Fear Returns

🎙️ The Speakers & Context

• The Format: Host-led interviews with rapid market breakdowns.
• The Key Players:
  • Host: Ed Elson, Prof G Markets host, delivers punchy market vitals and monologue tying AI themes.
  • Scott Devitt: Managing Director of Equity Research at Wedbush Securities; credible for tech sector coverage, especially hyperscalers like Alphabet.
  • Jared Holtz: Healthcare Equity Strategist at Mizuho; expert on pharma earnings, GLP-1 dynamics.
  • Rohan Goswami: Business Reporter at Semafor; on-the-ground insight into DC media/antitrust hearings.
• The Vibe: Fast-paced, analytical, cautiously bullish amid volatility.

🎣 The Executive Hook

• The "One Big Idea": Hyperscalers like Alphabet are aggressively front-loading AI capex (e.g., $175-185B in 2025), signaling real infrastructure demand that validates suppliers like NVIDIA while creating a 3-year "investment hill" before harvest-mode returns in 2027-28. This mirrors past cycles where capex digestion precedes outsized growth, turning short-term selloffs into buying opportunities in dislocated high-quality software firms adapting AI. Pharma shows parallel divergence: Eli Lilly thrives on volume offsetting pricing via superior execution, while Novo Nordisk falters.
• Why It Matters: Aligns with AI's J-curve—heavy upfront spend crushes multiples now but compounds domi